| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.39 | 0.03 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |